Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marios Athanasios Loupas
Observed name:
MA Loupas
Institution:
University of West Attica
Observed institution:
University of West Attica
ORCID:
0009-0003-9465-4733
Observed ORCID:
0009-0003-9465-4733
OpenAlex ID:
A5093586747
Economic burden and health-related quality of life in patients with neurofibromatosis type 1 in Greece
2023
·
Lamprini Sotiropoulou
, Marios Athanasios Loupas
, et al.
·
Open Health
·
4
PDF
Social/ economic burden and health-related quality of life in patients with Spinal Muscular Atrophy (SMA) in Greece
2023
·
Vasileios Kontogiannis
, Marios Athanasios Loupas
, et al.
·
Journal of Health Policy & Outcomes Research
·
3
PT35 Cost-Effectiveness Analysis of Ribociclib Plus Endocrine Therapy for the Treatment of HR/HER2 Early Breast Cancer in Greece
2025
·
Marios Athanasios Loupas
, Vasiliki Antonopoulou
, et al.
·
Value in Health
·
1
PDF
Willingness to Pay per QALY: A Systematic Review of Demand-Side Valuations with a Focus on Age and Disease Severity
2025
·
Marios Athanasios Loupas
, Kostas Athanasakis
, et al.
·
Applied Health Economics and Health Policy
·
1
A discount rate for economic evaluations for Health Technology Assessment in Greece
2026
·
Kostas Athanasakis
, Marios Athanasios Loupas
, et al.
·
Health Policy and Technology
EE298 Cost-Effectiveness of Brexucabtagene Autoleucel (Brexu-cel, CAR-T) for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma in Greece
2022
·
MA Loupas
, D Theodoratou
, et al.
·
Value in Health
PDF
EE165 Cost-Effectiveness Analysis of Liposomal Formulation of Daunorubicin and Cytarabine (CPX-351) for the Treatment of Adult Patients With Newly Diagnosed Therapy-Related AML or AML With Myelodysplasia-Related Changes in Greece
2022
·
MA Loupas
, K Lioliou
, et al.
·
Value in Health
Show more works
View as search
Works count:
7
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type